DK3302543T3 - Vaccinesammensætninger mod porcint reproduktions- og respirationssyndrom og porcint circovirus-associerede sygdomme - Google Patents

Vaccinesammensætninger mod porcint reproduktions- og respirationssyndrom og porcint circovirus-associerede sygdomme Download PDF

Info

Publication number
DK3302543T3
DK3302543T3 DK16804176.2T DK16804176T DK3302543T3 DK 3302543 T3 DK3302543 T3 DK 3302543T3 DK 16804176 T DK16804176 T DK 16804176T DK 3302543 T3 DK3302543 T3 DK 3302543T3
Authority
DK
Denmark
Prior art keywords
porcint
circovirus
reproduction
vaccine compositions
associated diseases
Prior art date
Application number
DK16804176.2T
Other languages
English (en)
Inventor
Yu-Hsin CHIEN
Meng-Ju Tsai
Pao-Yen Lai
Wei-I Chou
Hsiu-Kang Chang
Original Assignee
Reber Genetics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reber Genetics Co Ltd filed Critical Reber Genetics Co Ltd
Application granted granted Critical
Publication of DK3302543T3 publication Critical patent/DK3302543T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/572—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 cytotoxic response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/04—Fusion polypeptide containing a localisation/targetting motif containing an ER retention signal such as a C-terminal HDEL motif
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/095—Fusion polypeptide containing a localisation/targetting motif containing a nuclear export signal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
DK16804176.2T 2015-06-01 2016-05-27 Vaccinesammensætninger mod porcint reproduktions- og respirationssyndrom og porcint circovirus-associerede sygdomme DK3302543T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562169205P 2015-06-01 2015-06-01
PCT/US2016/034858 WO2016196383A1 (en) 2015-06-01 2016-05-27 Vaccine compositions against porcine reproductive and respiratory syndrome and porcine circovirus associated diseases

Publications (1)

Publication Number Publication Date
DK3302543T3 true DK3302543T3 (da) 2020-05-18

Family

ID=57397434

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16804176.2T DK3302543T3 (da) 2015-06-01 2016-05-27 Vaccinesammensætninger mod porcint reproduktions- og respirationssyndrom og porcint circovirus-associerede sygdomme

Country Status (11)

Country Link
US (1) US10010602B2 (da)
EP (1) EP3302543B1 (da)
JP (1) JP6676661B2 (da)
KR (1) KR102041032B1 (da)
CN (1) CN107847575B (da)
AU (1) AU2016271144B2 (da)
CA (1) CA2985381C (da)
DK (1) DK3302543T3 (da)
ES (1) ES2790527T3 (da)
TW (1) TWI621627B (da)
WO (1) WO2016196383A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11246915B2 (en) 2010-09-15 2022-02-15 Applied Molecular Transport Inc. Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
MX386785B (es) * 2017-06-29 2025-03-19 Centro De Investig Y Asistencia En Tecnologia Y Diseno Del Estado De Jalisco A C Proteína quimérica para la prevención y el diagnóstico del síndrome respiratorio y reproductivo porcino (prss).
KR20250174998A (ko) 2018-03-08 2025-12-15 어플라이드 몰레큘라 트랜스포트 인크. 경구 전달용 독소-유래 전달 구조체
CN113527511A (zh) * 2018-09-19 2021-10-22 天康生物股份有限公司 融合蛋白及其制备方法、应用、表达系统和疫苗
JP7487193B2 (ja) 2018-11-07 2024-05-20 アプライド モレキュラー トランスポート インコーポレイテッド 異種ペイロードの経口送達のためのコリックス由来担体
CN109762047B (zh) * 2019-02-27 2021-11-26 河南省农业科学院 与猪圆环病毒2型Cap蛋白特异性结合的多肽序列及其应用
CN110408602B (zh) * 2019-08-02 2021-03-19 天康制药(苏州)有限公司 Pcv2-prrsv重组病毒及其制备方法、基因、应用和疫苗
CN114675025B (zh) * 2022-03-29 2025-12-12 中国科学院苏州纳米技术与纳米仿生研究所 可用于diva的猪圆环病毒2型抗体检测试剂盒

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1000163B1 (en) * 1997-07-11 2005-10-19 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the Secretary of the Department of Health and Human Services Pseudomonas exotoxin a-like chimeric immunogens
US7314632B1 (en) 1997-07-11 2008-01-01 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Pseudomonas exotoxin A-like chimeric immunogens
EP1572933A4 (en) * 2002-02-13 2007-09-05 Univ Duke MODULATION OF THE IMMUNE RESPONSE BY POLYPEPTIDES AS AN ANSWER TO NONPEPTIDIC BINDING STRENGTH
WO2003084467A2 (en) * 2002-04-01 2003-10-16 Euro-Celtique S.A. Epitope constructs comprising antigen presenting cell targeting mechanisms
US8206950B2 (en) * 2003-06-09 2012-06-26 Animal Technology Institute Taiwan Fusion antigen used as vaccine and method of making them
US7595054B2 (en) 2003-06-09 2009-09-29 Healthbanks Biotech Co., Ltd. Fusion antigen used as vaccine
US7335361B2 (en) * 2003-06-09 2008-02-26 Animal Technology Institute Taiwan Fusion antigen used as vaccine
US7596054B2 (en) 2004-11-03 2009-09-29 Drs Sustainment Systems, Inc. Suppressed feature waveform for modulated sonar transmission
US7964200B2 (en) * 2005-05-18 2011-06-21 Children's Hospital & Research Center At Oakland Methods and compositions for immunizing against Chlamydia infection
US7465455B2 (en) * 2006-07-05 2008-12-16 Healthbanks Biotech Co., Ltd. Fusion protein of porcine reproductive and respiratory syndrome virus as PRRS vaccine
CN101104641B (zh) 2006-07-11 2012-04-18 生宝生物科技股份有限公司 作为猪生殖和呼吸道征候群疫苗的prrs病毒的融合蛋白
ES2384524T3 (es) 2006-07-29 2012-07-06 Healthbanks Biotech Co., Ltd. Proteína de fusión del virus del síndrome reproductor y respiratorio porcino como vacuna contra el SRRP
GB2467722B (en) * 2007-12-04 2012-03-07 Schweitzer Co Ltd A subunit vaccine for aquaculture
AU2009226077B2 (en) * 2008-03-20 2012-04-19 University Of Miami Heat shock protein gp96 vaccination and methods of using same
UA113192C2 (xx) 2011-12-06 2016-12-26 Імуногенна композиція проти цирковірусу свиней типу 2 (pcv2)
US9339536B2 (en) * 2012-12-05 2016-05-17 Thevax Genetics Vaccine Co., Ltd. Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses

Also Published As

Publication number Publication date
CN107847575A (zh) 2018-03-27
KR20180015185A (ko) 2018-02-12
JP2018516926A (ja) 2018-06-28
CA2985381A1 (en) 2016-12-08
EP3302543B1 (en) 2020-04-29
EP3302543A4 (en) 2018-12-05
US10010602B2 (en) 2018-07-03
KR102041032B1 (ko) 2019-11-27
AU2016271144B2 (en) 2018-10-25
TW201706296A (zh) 2017-02-16
CA2985381C (en) 2020-03-24
WO2016196383A1 (en) 2016-12-08
EP3302543A1 (en) 2018-04-11
US20160346377A1 (en) 2016-12-01
JP6676661B2 (ja) 2020-04-08
ES2790527T3 (es) 2020-10-28
AU2016271144A1 (en) 2017-11-30
CN107847575B (zh) 2021-12-17
TWI621627B (zh) 2018-04-21

Similar Documents

Publication Publication Date Title
DK3718565T3 (da) Vacciner mod respiratorisk virus
IL258931A (en) Therapeutic compounds and methods
DK3303396T5 (da) Antistoffer mod ox40 og anvendelser deraf
LT3513809T (lt) Medicininė kompozicija, apimanti tivozanibą
DK3357513T3 (da) Farmaceutisk sammensætning og anvendelse deraf
EP4397341C0 (en) AROMA INHALER
EP3491945A4 (en) FLAVOR INHALER
DK3095798T3 (da) Immunitetsforstærkende terapeutisk vaccine mod hpv og relaterede sygdomme
IL264065A (en) Oral gastroretentive formulations and uses thes thereof
DK3495023T3 (da) Semifluorerede forbindelser og sammensætninger deraf
HUE052095T2 (hu) Keratin kezelési készítmények és eljárások
DK3102200T3 (da) Terapeutisk forbindelse og sammensætning
EP3273950A4 (en) ADJUVANE COMPOSITIONS AND RELATED METHODS
DK3220750T3 (da) Oral rehydreringssammensætning og fremgangsmåder dertil
EP3436467A4 (en) INNOVATIVE COMPOSITIONS AND THERAPEUTIC PROCEDURES
DK3236934T3 (da) Farmaceutisk sammensætning, fremstilling og anvendelser deraf
DK3223796T3 (da) Farmaceutiske sammensætninger, fremstilling og anvendelser deraf
DK3244920T5 (da) Mund- og klovsyge-vaccine
DK3388085T3 (da) Farmaceutisk sammensætning og anvendelser deraf
DK3615502T3 (da) Terapeutiske forbindelser og fremgangsmåder
DK3231793T3 (da) Dihydropyromidin-2-on-forbindelser og medicinske anvendelser deraf
DK3482754T3 (da) Farmaceutiske sammensætninger og anvendelser rettet mod lysosomale lagringssygdomme
EP3443854C0 (en) AROMA INHALER
DK3383397T3 (da) Farmaceutiske sammensætninger indeholdende doravirin, tenofovirdisoproxilfumarat og lamivudin
DK3240821T3 (da) Lavdosis gashydrathæmmersammensætning og tilhørende fremgangsmåde